DOM Faculty Appointments & Promotions – June 2026
Congratulations to the following Chobanian & Avedisian School of Medicine DOM Faculty on their recent appointment or promotion!
Associate Professor
Anica Law, MD, MS, Pulmonary, Allergy, Sleep & Critical Care, is a pulmonary and critical care physician, clinical epidemiologist and health services researcher with a focus on understanding determinants of outcomes after critical illness. The goal of her research is to better inform decision-making during critical illness and the optimal delivery of care after acute critical illness. She is PI on the R01, “Quantifying Uncertainty to Inform Time-Limited Trials of Invasive Mechanical Ventilation” (scored in the 1st percentile at NIH/NHLBI), which seeks to improve patient and family engagement in early prognostication for mechanically ventilated patients. An attending pulmonologist at Boston Medical Center, Dr. Law also serves as deputy editor at CHEST Critical Care and on the American Thoracic Society (ATS) Project Review Committee. She previously served as chair of the ATS Critical Care Assembly Planning Committee, and has received ATS Fellow designation as a mark of distinction.
Beth Cohen, MD, Endocrinology, Diabetes & Nutrition, is an endocrinologist who specializes in gender-affirming hormone therapy and care for transgender and gender diverse individuals. Her additional areas of interest include the evaluation and treatment of hypogonadism (estrogen or testosterone deficiency) and polyendocrine metabolic ovarian syndrome or PMOS (previously polycystic ovarian syndrome/PCOS). She serves as medical director of the GenderCare Center and ambulatory co-medical director of the Endocrinology, Diabetes, Nutrition and Weight Management Clinic at Boston Medical Center (BMC). Dr. Cohen developed the PISCES curriculum on gender-affirming care for first-year medical students, directs the fourth-year medical student Gender Care elective, and contributes as a lecturer and subject-matter expert for the school’s Student Gender and Sexual Diversity Track. Dr. Cohen also provides education and clinical support on gender-affirming hormone therapy to clinicians at Boston University’s Student Health Services and mentors medical students and trainees across BMC.
Hanni Menn-Josephy, MD, Nephrology, specializes in the management of complex autoimmune renal diseases. Since 2017, she has served as director the Lupus and Autoimmune Multidisciplinary Clinic at Boston Medical Center, bridging the gap between nephrology and rheumatology to ensure patients receive coordinated, high-level care. As a site PI, she leads cutting-edge clinical trials including a Phase 1 study of CRISPR-Cas9-engineered T cells and a Phase 2 trial of CAR-T therapy for refractory lupus nephritis. Notably, her site recruited the first patient globally for the rapcabtagene autoleucel (CAR-T) study in January 2025. In addition, she serves as associate program director for the nephrology fellowship at BMC.
Umit Tapan, MD, Hematology & Medical Oncology, is physician-scientist who is an attending thoracic oncologist at Boston Medical Center (BMC) whose clinical interests are non-small cell lung cancer, small cell lung cancer, mesothelioma, immunotherapy and targeted therapy/precision medicine. His research interests center on reducing disparities in lung cancer treatment, improving access to new treatments. He has served as site PI at BMC for 16 therapeutic trials and currently manages seven active protocols funded by the National Cancer Institute and industry partners. Since 2019, he has served as co-director of the Thoracic Oncology Program within the BU-BMC Cancer Center, and in 2020 he was appointed director of inpatient medical operations for the section of hematology and medical oncology.